Yüklüyor......
Sustained enhancement of OCTN1 transporter expression in association with hydroxyurea induced gamma-globin expression in erythroid progenitors
The clinical benefits of hydroxyurea treatment in patients with sickle cell disease (SCD) are due largely to increased gamma-globin expression. However, mechanisms that control gamma-globin expression by hydroxyurea in erythroid progenitors are incompletely understood. Here, we investigated the role...
Kaydedildi:
| Yayımlandı: | Exp Hematol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5164842/ https://ncbi.nlm.nih.gov/pubmed/27616638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2016.09.001 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|